Hostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologists

Cancer immunology research

Volumn 2, Issue 7, 2014, Pages 598-605

  Sitkovsky, Michail V ^a   Hatfield, Stephen ^a   Abbott, Robert ^a   Belikoff, Bryan ^a   Lukashev, Dmitriy ^a   Ohta, Akio ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2A RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

CELL HYPOXIA; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOTHERAPY; NEOPLASMS; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

CELL HYPOXIA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNE TOLERANCE; IMMUNOTHERAPY; NEOPLASMS; RECEPTOR, ADENOSINE A2A; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84964315622     PISSN: None     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-14-0075     Document Type: Review

References (0)